
Summary of the 14th WFH Global Forum on Advances and Access to Safe Treatment Products for Bleeding Disorders
A summary of discussions held at the Fourteenth WFH Global Forum on Advances and Access to Safe Treatment Products for
Year: 2020
Language: English
Author(s): World Federation of Hemophilia
Listen as Glenn Pierce, MD, PhD (WFH VP Medical), Flora Peyvandi, MD, PhD, Magdy El Ekiaby, MD, Cedric Hermans, MD, PhD, and Radoslaw Kaczmarek, PhD, provide the global bleeding disorders community with up-to-date information on COVID-19. This 1-hour webinar, presented on April 9, 2020, also addressed participants’ questions and concerns.
To download a pdf of the slides of the webinar, click the icon below.
This webinar has been transcribed. Please click on the icon below to access a summary of the transcript.

A summary of discussions held at the Fourteenth WFH Global Forum on Advances and Access to Safe Treatment Products for

Also Available In: English, Spanish, French, Arabic, Russian, Simplified Chinese This is not an official WFH translation. This resource has

The WFH Guidelines for the Management of Hemophilia: AAV Gene Therapy provide the first comprehensive, evidence-based recommendations to support the

Raising funds requires careful research and detailed planning, as well as creativity and good business practices. The second edition of

The 2026 version is available in: SpanishThe 2018 version booklet is available in: English, Arabic, French, Russian, Spanish, Simplified Chinese Using

The 3rd edition has also been translated into the following languages, with permission from the WFH, by NMOs/Other Organizations: Georgian,